If you take more Quetiapina Qualigen Farma than your doctor prescribed, you may feel drowsy, feel dizzy, and experience abnormal heartbeats. Contact your doctor or nearest hospital immediately. Bring your Quetiapina Qualigen Farma tablets with you. You can also call the Toxicological Information Service, Tf: 915620420, indicating the medication and the amount taken.
If you forget to take Quetiapina Qualigen Farma
If you forget to take a dose, take it as soon as you remember. If it is almost time to take the next dose, wait until then. Do not take a double dose to make up for the missed dose.
If you interrupt treatment with Quetiapina Qualigen Farma
If you stop taking Quetiapina Qualigen Farma abruptly, you may be unable to sleep (insomnia), or you may feel nausea, or you may experience headaches, diarrhea, vomiting, dizziness, or irritability. Your doctor may suggest reducing the dose gradually before stopping treatment.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medications, this medication may cause side effects, although not everyone will experience them.
Very common side effects (may affect more than 1 in 10 people):
·Dizziness (may lead to falls), headache, dry mouth.
·Sensation of drowsiness (which may disappear over time as you continue to take quetiapine), (may lead to falls).
·Withdrawal symptoms (symptoms that occur when you stop taking quetiapine), which include insomnia, nausea, headache, diarrhea, vomiting, dizziness, and irritability. It is recommended to taper off gradually over a period of at least 1 to 2 weeks.
·Weight gain.
·Abnormal muscle movements. These include difficulty initiating muscle movements, tremor, sensation of restlessness or muscle rigidity without pain.
·Changes in the amount of certain fats (triglycerides and total cholesterol).
Common side effects (may affect up to 1 in 10 people):
·Fast heart rate.
·Feeling like your heart is pounding, beating too fast, or has irregular heartbeats.
·Constipation, indigestion.
·Sensation of weakness.
·Swelling of arms or legs.
·Low blood pressure when standing. This may cause you to feel dizzy or faint (may lead to falls).
·Increased blood sugar levels.
·Blurred vision.
·Abnormal dreams and nightmares.
·Feeling hungrier.
·Feeling irritable.
·Speech and language disorder.
·Thoughts of suicide and worsening of depression.
·Shortness of breath.
·Vomiting (mainly in elderly people).
·Fever.
·Changes in the amount of thyroid hormones in the blood.
·Decrease in the number of certain types of blood cells.
·Increases in liver enzymes measured in the blood.
·Increases in prolactin hormone in the blood. The increases in prolactin hormone may, in rare cases, lead to the following:
oBoth in men and women having breast swelling and unexpected milk production.
oIn women not having a menstrual period or having irregular periods.
Uncommon side effects (may affect up to 1 in 100 people):
·Seizures or convulsions.
·Allergic reactions that may include hives, skin swelling, and swelling around the mouth.
·Unpleasant sensations in the legs (also known as restless leg syndrome).
·Difficulty swallowing.
·Involuntary movements, mainly of the face or tongue.
·Sexual dysfunction.
·Diabetes.
·Change in the heart's electrical activity seen on an ECG (prolongation of the QT interval).
·Slower than normal heart rate that may occur at the start of treatment and may be associated with low blood pressure and fainting.
·Difficulty urinating.
·Fainting (may lead to falls).
·Stuffy nose.
·Decrease in the number of red blood cells in the blood.
·Decrease in the amount of sodium in the blood.
Rare side effects (may affect up to 1 in 1,000 people):
·A combination of high temperature (fever), sweating, muscle stiffness, feeling very drowsy or dizzy (a condition known as "neuroleptic malignant syndrome").
·Yellowish discoloration of the skin and eyes (jaundice).
·Inflammation of the liver (hepatitis).
·Long-lasting and painful erection (priapism).
·Swelling of the breasts and unexpected milk production (galactorrhea).
·Menstrual disorder.
·Clots in the veins, especially in the legs (the symptoms include swelling, pain, and redness in the leg), which may travel through the blood vessels to the lungs causing chest pain and difficulty breathing. If you notice any of these symptoms, seek medical attention immediately.
·Walking, talking, eating, or other activities while you are asleep.
·Decrease in body temperature (hypothermia).
·Inflammation of the pancreas.
·A condition (known as "metabolic syndrome") where you may experience a combination of 3 or more of the following effects: increase in fat around your abdomen, decrease in "good" cholesterol (HDL-C), increase in a type of fat in the blood called triglycerides, increase in blood pressure, and increase in blood sugar levels.
·A combination of fever, symptoms similar to the flu, sore throat, or any other infection with a very low white blood cell count, a condition known as agranulocytosis.
·Intestinal obstruction.
·Increased creatine phosphokinase in the blood (a substance found in muscles).
Very rare side effects (may affect up to 1 in 10,000 people):
·Severe rash, blisters, or red spots on the skin.
·Severe allergic reaction (known as anaphylaxis) that may cause difficulty breathing or shock.
·Quick swelling of the skin, usually around the eyes, lips, and throat (angioedema).
·Severe skin condition known as Stevens-Johnson syndrome.
·Uncontrolled secretion of a hormone that controls urine volume.
·Breakdown of muscle fibers and muscle pain (rhabdomyolysis).
Not known (the frequency cannot be estimated from the available data):
·Red rash with irregular red spots (erythema multiforme).
·Severe allergic reaction with symptoms such as fever and blisters on the skin and peeling of the skin (toxic epidermal necrolysis).
·Symptoms of withdrawal in newborn babies of mothers who have used quetiapine during pregnancy.
·Medication rash with eosinophilia and systemic symptoms (DRESS, for its acronym in English). Generalized rash, high body temperature, elevated liver enzymes, abnormal blood counts (eosinophilia), swollen lymph nodes, and other organs involved (medication rash with eosinophilia and systemic symptoms, also known as DRESS). If you develop these symptoms, stop using quetiapine and contact your doctor or seek medical attention immediately.
·Stroke.
·Cardiac muscle disorder (cardiomyopathy).
·Inflammation of the heart muscle (myocarditis).
·Inflammation of blood vessels (vasculitis), often with a skin rash with small red or purple spots.
The class of medications to which Quetiapine Qualigen belongs may cause heart rhythm problems that can be severe and, in severe cases, be fatal.
Some side effects are only observed when a blood test is performed. These include changes in the amount of certain fats (triglycerides and total cholesterol) or sugar in the blood, changes in the amount of thyroid hormones in the blood, increases in liver enzymes, decreases in the number of certain types of blood cells, decreases in the number of red blood cells, increases in creatine phosphokinase in the blood (a substance found in muscles), decreases in the amount of sodium in the blood, and increases in the amount of prolactin hormone in the blood. The increases in prolactin hormone may, in rare cases, lead to the following:
·Both in men and women having breast swelling and unexpected milk production.
·In women not having a menstrual period or having irregular periods.
Your doctor may ask you to have blood tests from time to time.
Side effects in children and adolescents
The same side effects that may occur in adults may also occur in children and adolescents.
The following side effects have been observed more frequently in children and adolescents or have not been observed in adults:
Very common side effects (may affect more than 1 in 10 people):
·Increased amount of a hormone called prolactin in the blood. The increases in prolactin hormone may, in rare cases, lead to the following:
-Both in boys and girls having breast swelling and unexpected milk production.
-In girls not having a menstrual period or having irregular periods.
·Increased appetite.
·Vomiting.
·Abnormal muscle movements. These include difficulty initiating muscle movements, tremors, sensation of restlessness or muscle rigidity without pain.
·Increased blood pressure.
Common side effects (may affect up to 1 in 10 people):
·Sensation of weakness, fainting (may lead to falls).
·Stuffy nose.
·Feeling irritable.
Reporting of side effects
If you experience any type of side effect, consult your doctor, pharmacist, or nurse, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through the Spanish System for the Pharmacovigilance of Medicines for Human Use: https//www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.
Do not use this medication after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
Thismedication does not require special storage conditions.
Medicines should not be disposed of through drains or in the trash. Dispose of the packaging and medicines you no longer need at the SIGRE point at the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medicines you no longer need. By doing so, you will help protect the environment.
The active ingredient is quetiapine. The tablets contain50 mg of quetiapine (as quetiapine fumarate).
The other components are:
Tablet core: lactose, copolymer of methacrylic acid – ethyl acrylate (1:1), crystalline maltose type A, magnesium stearate, and talc.
Tablet coating: Copolymer of methacrylic acid – ethyl acrylate (1:1), type A, triethyl citrate.
Appearance of Quetiapina Qualigen Farma, and content of the container
The prolonged-release tablets of 50 mg are white or off-white, round, biconvex, with “50” engraved on one face, 7.1 mm in diameter, and 3.2 mm in thickness.
It is presented in aluminum/PVC/PCTFE blister in a cardboard box.
The sizes of the containers are: 10, 30, 50, 60, 100, and 180 tablets.
Only some container sizes may be commercially marketed.
Holder of the marketing authorization
Neuraxpharm Spain, S.L.U.
Avda. Barcelona, 69
08970 Sant Joan Despí
Barcelona
Responsible for manufacturing
Pharmathen International, S.A.
Industrial Park Sapes Rodopi Prefecture Block Nº 5
Rodopi 69300
Greece
or
Pharmathen, S.A.
Dervenakion 6
Pallini Attiki, 15351
Greece
or
neuraxpharm Arzneimittel GmbH
Elisabeth-Selbert-Str. 23
40764 Langenfeld
Germany
Last review date of this leaflet: June 2024
Detailed and updated information on this medicine is available on the website of the Spanish Agency of Medicines and Medical Products (AEMPS)http://www.aemps.gob.es/
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.